Spectrum of antimicrobial activity associated with ionic colloidal silver

Journal of Alternative and Complementary Medicine

Volumn 19, Issue 3, 2013, Pages 224-231

  Morrill, Kira ^a   May, Kathleen ^a   Leek, Daniel ^a   Langland, Nicole ^b   Jeane, La Deana ^a   Ventura, Jose ^a   Skubisz, Corey ^a   Scherer, Sean ^a   Lopez, Eric ^a   Crocker, Ephraim ^a   Peters, Rachel ^a   Oertle, John ^a   Nguyen, Krystine ^a   Just, Scott ^a   Orian, Michael ^a   Humphrey, Meaghan ^a   Payne, David ^a   Jacobs, Bertram ^b   Waters, Robert ^a,b   Langland, Jeffrey ^a,b  

^a Southwest College Naturopathic Med   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IONIC COLLOIDAL SILVER; SILVER; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTEROIDES VULGATUS; CANDIDA ALBICANS; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOTOXICITY TEST; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG EXPOSURE; ENCEPHALOMYOCARDITIS VIRUS; ESCHERICHIA COLI; FEMALE; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; GROWTH INHIBITION; HUMAN; HUMAN CELL; LACTOBACILLUS ACIDOPHILUS; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL; REOVIRUS; SALMONELLA TYPHIMURIUM; SHIGELLA SONNEI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; VACCINIA VIRUS; VIRUS CULTURE; VIRUS REPLICATION; VIRUS STRAIN;

ANTI-INFECTIVE AGENTS; BACTERIA; COLLOIDS; FUNGI; IONS; SILVER; SILVER COMPOUNDS; VIRUSES;

EID: 84875470461     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2011.0681     Document Type: Article

References (27)

1. Brett D. A discussion of silver as an antimicrobial agent: Alleviating the confusion. Ostomy/Wound Manage 2006;52: 34-41.
2. Lansdown ABG. Silver in health care: Antimicrobial effects and safety in use. Curr Probl Dermatol 2006; 33:17-34.
3. Fox CL, Modak SM. Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother 1974;5:582-586.
4. Australian Therapeutic Goods Administration. Regulation of Colloidal Silver and Related Products. Online document at: http:tga.gov.au/docs/html/ csilver.htm AccessedMay10, 2011.
5. Food and Drug Administration (FDA). Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final Rule. Fed Regist 64 (158):44653-8. August 1999. PMID 10558603.
6. Van Hasselt P, Gashe BA, Ahmad J. Colloidal silver as an antimicrobial agent: Fact or fiction. J Wound Care 2004;13: 154-155.
7. Chopra I. The increasing use of silver-based products as antimicrobial agents: A useful development or a cause for concern? J Antimicrob Chemother 2007;59:587-590.
8. Kim J, Kuk E, Yu K, et al. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med 2007;3:95-101.
9. Brentano L, Margraf H, Monafo W, Moyer C. Antibacterial efficacy of a colloidal silver complex. Surg Forum 1996;17: 76-78.
10. Silvestry-Rodriguez N, Sicairos-Ruelas E, Gerba C, Bright K. Silver as a disinfectant. Rev Environ Contamin Toxicol 2007;191:23-45.
11. Lansdown ABG. Silver 1: Its antibacterial properties and mechanism of action. J Wound Care 2002;11:25-130.
12. Feng QL, Wu J, Chen GQ, et al. A mechanistic study of the antibacterial effect of silver and ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000;52: 662-668.
13. Dibrov P, Dzioba J, Gosink K, Hase C. Chemiosmotic mechanism of antimicrobial activity of Ag in Vibrio cholerae. Antimicrob Agents Chemother 2002;46:2668-2670.
14. Lok C, Ho C, Chen R, et al. Silver nanoparticles: Partial oxidation and antibacterial activities. J Biol Inorganic Chem 2007;12:527-534.
15. Mullen M, Wolf D, Ferris F, et al. Bacterial sorption of heavy metals. Appl Environ Microbiol 1989;55:3143-3149.
16. Elechiguerra J, Burt J, Morones J, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 2005;3:6-16.
17. Shimizu F, Shimizu Y, Kumagai K. Specific inactivation of herpes simplex virus by silver nitrate at low concentration and biological activities of the inactivated virus. Antimicrob Agents Chemother 1976;10:57-63.
18. Bogdanchikova NE, Kurbatov AV, Tret'yakov VV, Rodionov PP. Activity of colloidal silver preparations towards smallpox virus. Pharm Chem J 1992;26:778-779.
19. Smith GL, Vanderplasschen A, Law M. The formation and function of extracellular enveloped vaccina virus. J Gen Virol 2002;83:2915-2931.
20. Kim K, Sung W, Suh B, et al. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals 2009;22:235-242.
21. Fung M, Bowen D. Silver products for medical indications: Risk-benefit assessment. Clin Toxicol 1996;34:119-126.
22. Lansdown ABG. Silver 2: Toxicity in mammmals and how its products aid wound repair. J Wound Care 2002;11:173-177.
23. Chang A, Khosravi V, Egbert B. A case of argyria after colloidal silver ingestion. J Cutan Pathol 2006;33:809-811.
24. Mirsattari SM, Hammond RR, Sharpe MD, et al. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology 2004;62:1408-1410.
25. Environmental Protection Agency (EPA). Silver (casrn 7440-22-4) Online document at: www.epa.gov/NCEA/iris/subst/0099.htm Accessed March 4, 2011.
26. Fowler BA, Nordberg GF. In: Frieberg L, Norberg GF, Vouk VB, eds. Handbook on the Toxicology of Metals. 1st ed. New York: Elsevier/North-Holland Biomedical Press, 1996:579-586.
27. Baral VR, Dewar AL, Connett GJ. Colloidal silver for lung disease in cystic fibrosis. J R Soc Med 2008;101:51-52.